Funding and investment
Funding content
![£9m £9m](/en/t4-media/one-web/university/research/health/biomedical/figures/9.gif)
Funding
£9m Inverness and Highland City-Region Deal funding committed from the UK Government to support health and life science innovation
Partnerships content
![52 52](/en/t4-media/one-web/university/research/health/biomedical/figures/52.gif)
Partnerships
52 successful commercial partnerships with UK and international companies since 2015
Collaborations content
![62 62](/en/t4-media/one-web/university/research/health/biomedical/figures/62.gif)
Collaborations
62 collaborations with universities across the globe (2015-today)
World leading content
![69% 69%](/en/t4-media/one-web/university/research/health/biomedical/figures/69.gif)
World leading
69% of University of the Highlands and Islands health research deemed internationally excellent or world leading (2014 UK REF)
Active academics content
Grant income content
![50+ 50+](/en/t4-media/one-web/university/research/health/biomedical/figures/50.gif)
Active academics
More than 50 research active academics and clinician scientists
Grant income
£17m in new research grant income generated since 2015
A selection of major recent funding awards
- 2019: £1.6m Legacy funding for Causes of Schizophrenia
- 2017: £1.5m ESF Developing Scotland’s Workforce (12 studentships)
- 2017: £1.3m Inter-Reg Eastern Corridor Medical Engineering Centre
- 2017: £9m UK Government Inverness and Highland City-Region Deal
- 2016: £4m Highlands and Islands Enterprise for development of School of Health
- 2012: £290k British Heart Foundation
- 2009: £1.5m ERDF funding: Lipidomics Facility
- 2009: £201k Chief Scientist Office
- 2009: £110k Schizophrenia Association of Great Britain
- 2009: 181k Schizophrenia Association of Great Britain
- 2009: £2m European Regional Development Fund (UHI Strategic Delivery Body)
- 2008: £106k Chief Scientist Office
- 2005: £1.2m British Heart Foundation Programme